Genetic Polymorphisms & The Risk for Sepsis After Trauma
- Conditions
- Trauma
- Interventions
- Other: blood sampling
- Registration Number
- NCT02021552
- Lead Sponsor
- University of Washington
- Brief Summary
The specific aim of this is to establish a cohort of severely injured patients admitted to our trauma center. Investigators will collect DNA, utilizing discarded blood samples, from 3000 injury victims in an effort to identify perhaps 50 - 100 single-nucleotide polymorphisms (SNP) (out of 1000s) that can be used, when taken together, to identify patients at highest risk for developing complicated sepsis and death.
- Detailed Description
The specific aim of this is to establish a cohort of severely injured patients admitted to our trauma center. Investigators will collect DNA, utilizing discarded blood samples, from 3000 injury victims in an effort to identify perhaps 50 - 100 single-nucleotide polymorphisms (SNP) (out of 1000s) that can be used, when taken together, to identify patients at highest risk for developing complicated sepsis and death
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 357
Admitted to the Intensive Care Unit (ICU) at Harborview Medical Center after suffering a traumatic injury
- ability to obtain a 5 ml blood sample
- Expected to be in the ICU for more than 24 hours
- We will exclude subjects with chronic medical conditions for the reasons stated above as well as vulnerable populations (children, pregnant females, and prisoners)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description trauma patients blood sampling trauma patients 18 years or older requiring treatment in the ICU \>24 hours. All subjects will undergo blood sampling.
- Primary Outcome Measures
Name Time Method Investigators aim to identify up to 100 single-nucleotide polymorphisms (out of 1000s) that can be used, when taken together, to identify patients at highest risk for developing complicated sepsis and death. 3 years The investigators will be studying whether baseline genetic difference can be used in the future to identify patients at high risk and conversely those at low risk for complicated post-traumatic infections.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Harborview Medical Center
🇺🇸Seattle, Washington, United States